KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcosa (ACA) Capital Expenditures: 2017-2025

Historic Capital Expenditures for Arcosa (ACA) over the last 8 years, with Sep 2025 value amounting to $39.6 million.

  • Arcosa's Capital Expenditures rose 15.12% to $39.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $154.7 million, marking a year-over-year decrease of 20.71%. This contributed to the annual value of $189.7 million for FY2024, which is 6.78% down from last year.
  • As of Q3 2025, Arcosa's Capital Expenditures stood at $39.6 million, which was up 42.45% from $27.8 million recorded in Q2 2025.
  • Over the past 5 years, Arcosa's Capital Expenditures peaked at $58.7 million during Q4 2023, and registered a low of $19.3 million during Q3 2021.
  • In the last 3 years, Arcosa's Capital Expenditures had a median value of $47.6 million in 2024 and averaged $45.0 million.
  • As far as peak fluctuations go, Arcosa's Capital Expenditures skyrocketed by 114.40% in 2022, and later slumped by 41.60% in 2025.
  • Quarterly analysis of 5 years shows Arcosa's Capital Expenditures stood at $24.3 million in 2021, then soared by 114.40% to $52.1 million in 2022, then grew by 12.67% to $58.7 million in 2023, then dropped by 9.20% to $53.3 million in 2024, then increased by 15.12% to $39.6 million in 2025.
  • Its last three reported values are $39.6 million in Q3 2025, $27.8 million for Q2 2025, and $34.0 million during Q1 2025.